DK1603573T3 - Anvendelse af dipyridamol i kombination med acetylsalicylsyre og en angiotensin II-antagonist til forebyggelse af slagtilfælde - Google Patents

Anvendelse af dipyridamol i kombination med acetylsalicylsyre og en angiotensin II-antagonist til forebyggelse af slagtilfælde

Info

Publication number: DK1603573T3
Authority: DK; Denmark
Prior art keywords: dipyridamole; angiotensin; antagonist; combination; acetylsalicylic acid
Prior art date: 2003-02-13

Application number

DK04709596T

Other languages

English (en)

Inventor

James C Gilbert

Axel Riedel

Lutz Hilbrich

David Michael Humphreys

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-13

Filing date

2004-02-10

Publication date

2008-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32870338&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1603573(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-02-10 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2008-09-15 Application granted granted Critical

2008-09-15 Publication of DK1603573T3 publication Critical patent/DK1603573T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
General Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK04709596T 2003-02-13 2004-02-10 Anvendelse af dipyridamol i kombination med acetylsalicylsyre og en angiotensin II-antagonist til forebyggelse af slagtilfælde DK1603573T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10306179A DE10306179A1 (de)	2003-02-13	2003-02-13	Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
EP03018212		2003-08-08
PCT/EP2004/001208 WO2004071385A2 (en)	2003-02-13	2004-02-10	Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention

Publications (1)

Publication Number	Publication Date
DK1603573T3 true DK1603573T3 (da)	2008-09-15

Family

ID=32870338

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04709596T DK1603573T3 (da)	2003-02-13	2004-02-10	Anvendelse af dipyridamol i kombination med acetylsalicylsyre og en angiotensin II-antagonist til forebyggelse af slagtilfælde

Country Status (29)

Country	Link
US (5)	US20040214802A1 (da)
EP (2)	EP1603573B8 (da)
JP (1)	JP2006517557A (da)
KR (1)	KR20050100676A (da)
CN (1)	CN1750830A (da)
AR (1)	AR043173A1 (da)
AT (1)	ATE395921T1 (da)
AU (1)	AU2004212305A1 (da)
BR (1)	BRPI0407457A (da)
CA (1)	CA2515941A1 (da)
DE (2)	DE10306179A1 (da)
DK (1)	DK1603573T3 (da)
EA (1)	EA200501231A1 (da)
EC (1)	ECSP055963A (da)
ES (1)	ES2308147T3 (da)
HR (1)	HRP20050713A2 (da)
MX (1)	MXPA05008572A (da)
NO (1)	NO20054216L (da)
NZ (1)	NZ542302A (da)
PE (1)	PE20050191A1 (da)
PL (1)	PL378204A1 (da)
PT (1)	PT1603573E (da)
RS (1)	RS20050618A (da)
SI (1)	SI1603573T1 (da)
TW (1)	TW200501957A (da)
UA (1)	UA83481C2 (da)
UY (1)	UY28182A1 (da)
WO (1)	WO2004071385A2 (da)
ZA (1)	ZA200505956B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10335027A1 (de) *	2003-07-31	2005-02-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verwendung von Angiotensin II Rezeptor Antagonisten
DE10306179A1 (de) *	2003-02-13	2004-08-26	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
CA2437709A1 (en) *	2003-08-08	2005-02-20	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Use of dipyridamole, acetylsalicylic acid and an angiotensin ii antagonist for treatment and prevention of vascular events
JP2005060359A (ja) *	2003-08-13	2005-03-10	Boehringer Ingelheim Pharma Gmbh & Co Kg	血管系病態の治療及び予防のためのジピリダモール、アセチルサリチル酸及びアンギオテンシンｉｉ拮抗薬の使用
WO2009080301A1 (en) *	2007-12-21	2009-07-02	Boehringer Ingelheim International Gmbh	Treatment and prevention of ischaemic cerebral lesions and cerebrovascular cognitive impairment using a treatment regimen consisting of dipyridamole and an angiotensin ii receptor blocker in patients with previous stroke
US20100069326A1 (en) *	2008-02-14	2010-03-18	Wasimul Haque	Combination Therapies to Treat Cardio- and Cerebro-Vascular Disorders
WO2009100534A1 (en) *	2008-02-14	2009-08-20	Kardiatech, Inc.	Combination therapy to treat vascular disorders
WO2010097501A2 (en) *	2009-02-26	2010-09-02	Orion Corporation	A combination treatment
US8633158B1 (en) *	2012-10-02	2014-01-21	Tarix Pharmaceuticals Ltd.	Angiotensin in treating brain conditions
CN107106541A (zh)	2015-01-28	2017-08-29	瑞采生技有限公司	用于增强PPARγ表现及核转位之化合物及其医疗用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3031458A (en) *	1958-02-05	1962-04-24	Ciba Pharm Prod Inc	Isoindolines
US3031450A (en)	1959-04-30	1962-04-24	Thomae Gmbh Dr K	Substituted pyrimido-[5, 4-d]-pyrimidines
US3317279A (en) *	1963-03-15	1967-05-02	Pennsalt Chemicals Corp	Polymorph of calcium disilicide and its method of preparation
JPS5671074A (en) *	1979-11-12	1981-06-13	Takeda Chem Ind Ltd	1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
DE3000979A1 (de)	1980-01-12	1981-07-23	Dr. Karl Thomae Gmbh, 7950 Biberach	Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
US4318477A (en) *	1980-09-22	1982-03-09	Kerpe Stase Z	Pharmaceutical package
DE3124090A1 (de)	1981-06-19	1983-01-05	Dr. Karl Thomae Gmbh, 7950 Biberach	Neue orale dipyridamolformen
CA1334092C (en)	1986-07-11	1995-01-24	David John Carini	Angiotensin ii receptor blocking imidazoles
DE3627423A1 (de)	1986-08-13	1988-02-18	Thomae Gmbh Dr K	Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung
US5015651A (en)	1988-01-07	1991-05-14	E. I. Du Pont De Nemours And Company	Treatment of hypertension with 1,2,4-angiotensin II antagonists
CA1338238C (en)	1988-01-07	1996-04-09	David John Carini	Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US4880804A (en) *	1988-01-07	1989-11-14	E. I. Du Pont De Nemours And Company	Angiotensin II receptor blocking benzimidazoles
SI9210098B (sl)	1991-02-06	2000-06-30	Dr. Karl Thomae	Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
EP1013273A1 (en)	1998-12-23	2000-06-28	Novartis AG	Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors
SE9903028D0 (sv) *	1999-08-27	1999-08-27	Astra Ab	New use
EP1093814A1 (en) *	1999-10-22	2001-04-25	Boehringer Ingelheim Pharma KG	Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
JP2002138054A (ja) *	2000-08-25	2002-05-14	Takeda Chem Ind Ltd	フィブリノーゲン低下剤
JP2002293742A (ja) *	2001-01-29	2002-10-09	Takeda Chem Ind Ltd	鎮痛・抗炎症剤
JP2003212758A (ja) *	2001-03-16	2003-07-30	Takeda Chem Ind Ltd	徐放性製剤の製造法
DE10306179A1 (de) *	2003-02-13	2004-08-26	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe

2003
- 2003-02-13 DE DE10306179A patent/DE10306179A1/de not_active Withdrawn
2004
- 2004-02-03 US US10/770,971 patent/US20040214802A1/en not_active Abandoned
- 2004-02-10 WO PCT/EP2004/001208 patent/WO2004071385A2/en not_active Ceased
- 2004-02-10 KR KR1020057014826A patent/KR20050100676A/ko not_active Withdrawn
- 2004-02-10 SI SI200430789T patent/SI1603573T1/sl unknown
- 2004-02-10 PT PT04709596T patent/PT1603573E/pt unknown
- 2004-02-10 BR BR0407457-2A patent/BRPI0407457A/pt not_active IP Right Cessation
- 2004-02-10 DK DK04709596T patent/DK1603573T3/da active
- 2004-02-10 NZ NZ542302A patent/NZ542302A/en unknown
- 2004-02-10 EP EP04709596A patent/EP1603573B8/en not_active Expired - Lifetime
- 2004-02-10 US US10/544,239 patent/US20070004687A1/en not_active Abandoned
- 2004-02-10 EA EA200501231A patent/EA200501231A1/ru unknown
- 2004-02-10 RS YUP-2005/0618A patent/RS20050618A/sr unknown
- 2004-02-10 AT AT04709596T patent/ATE395921T1/de not_active IP Right Cessation
- 2004-02-10 AU AU2004212305A patent/AU2004212305A1/en not_active Abandoned
- 2004-02-10 EP EP06121998A patent/EP1733729A1/en not_active Withdrawn
- 2004-02-10 ES ES04709596T patent/ES2308147T3/es not_active Expired - Lifetime
- 2004-02-10 UY UY28182A patent/UY28182A1/es not_active Application Discontinuation
- 2004-02-10 PL PL378204A patent/PL378204A1/pl not_active Application Discontinuation
- 2004-02-10 DE DE602004013937T patent/DE602004013937D1/de not_active Expired - Fee Related
- 2004-02-10 MX MXPA05008572A patent/MXPA05008572A/es active IP Right Grant
- 2004-02-10 CN CNA2004800041078A patent/CN1750830A/zh active Pending
- 2004-02-10 HR HR20050713A patent/HRP20050713A2/xx not_active Application Discontinuation
- 2004-02-10 CA CA002515941A patent/CA2515941A1/en not_active Abandoned
- 2004-02-10 JP JP2006501788A patent/JP2006517557A/ja active Pending
- 2004-02-11 PE PE2004000151A patent/PE20050191A1/es not_active Application Discontinuation
- 2004-02-12 TW TW093103344A patent/TW200501957A/zh unknown
- 2004-02-13 AR ARP040100446A patent/AR043173A1/es unknown
- 2004-10-02 UA UAA200508697A patent/UA83481C2/uk unknown
2005
- 2005-08-11 EC EC2005005963A patent/ECSP055963A/es unknown
- 2005-09-12 NO NO20054216A patent/NO20054216L/no not_active Application Discontinuation
2006
- 2006-02-09 ZA ZA200505956A patent/ZA200505956B/en unknown
- 2006-06-29 US US11/478,184 patent/US20060241089A1/en not_active Abandoned
2007
- 2007-12-18 US US11/958,499 patent/US20080113949A1/en not_active Abandoned
2008
- 2008-01-15 US US12/014,181 patent/US20080188497A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2006517557A (ja)	2006-07-27
EP1733729A1 (en)	2006-12-20
EP1603573B1 (en)	2008-05-21
CN1750830A (zh)	2006-03-22
ECSP055963A (es)	2006-01-16
DE10306179A1 (de)	2004-08-26
UA83481C2 (uk)	2008-07-25
HRP20050713A2 (en)	2006-09-30
SI1603573T1 (sl)	2008-10-31
WO2004071385A2 (en)	2004-08-26
PE20050191A1 (es)	2005-04-12
ES2308147T3 (es)	2008-12-01
MXPA05008572A (es)	2005-11-04
US20060241089A1 (en)	2006-10-26
PL378204A1 (pl)	2006-03-20
US20080188497A1 (en)	2008-08-07
KR20050100676A (ko)	2005-10-19
RS20050618A (sr)	2007-09-21
US20040214802A1 (en)	2004-10-28
EP1603573A2 (en)	2005-12-14
ATE395921T1 (de)	2008-06-15
EA200501231A1 (ru)	2006-02-24
PT1603573E (pt)	2008-06-26
EP1603573B8 (en)	2009-04-01
US20070004687A1 (en)	2007-01-04
CA2515941A1 (en)	2004-08-26
NO20054216D0 (no)	2005-09-12
TW200501957A (en)	2005-01-16
NZ542302A (en)	2008-12-24
DE602004013937D1 (de)	2008-07-03
BRPI0407457A (pt)	2006-01-31
US20080113949A1 (en)	2008-05-15
NO20054216L (no)	2005-09-12
WO2004071385A3 (en)	2005-01-06
AU2004212305A1 (en)	2004-08-26
AR043173A1 (es)	2005-07-20
ZA200505956B (en)	2006-03-29
UY28182A1 (es)	2004-09-30

Publication	Publication Date	Title
DK1891973T3 (da)	2010-10-18	Kombinationer omfattende antimuskarine midler og PDE4-hæmmere
DE602005012825D1 (de)	2009-04-02	Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren
LTC1761540I2 (lt)	2019-04-10	Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės-delta inhibitoriai
ATE435859T1 (de)	2009-07-15	Gyraseinhibitoren und deren verwendungen
IS7700A (is)	2005-02-17	Ný spíróþétt kínasólínón og notkun þeirra sem fosfórdíesterasa hindrar
DK1531819T3 (da)	2009-04-20	Anvendelse af ikappab kinaseinhibitorer i smertebehandlingen
HRP20160880T1 (hr)	2016-09-23	Formulacija obložene tablete i postupak
DK3366283T3 (da)	2021-11-22	Direkte sammenpresningsformulering og fremgangsmåde
EP1827389A4 (en)	2012-09-12	PROLONGED RELEASE NANOPARTICLE COMPOSITIONS AND METHODS OF USE
EP1653970A4 (en)	2008-10-15	GSK-3 HEMMER AND ITS USES
DK1597238T3 (da)	2007-09-10	HIV-replicationshæmmende pyrimidiner og triaziner
DK1583542T3 (da)	2008-09-22	Sammensætninger og fremgangsmåder til antiviral kombinationsterapi
DK1765793T3 (da)	2013-01-14	Anacetrapib og andre cetp-inhibitorer
EP1694821A4 (en)	2010-11-24	PROBABLE RECONSTRUCTION OF SURFACES IN OCCLUSIVE REGIONS BY CALCULATED SYMMETRY
EP1490373A4 (en)	2009-11-11	Inhibitors of nucleoside phosphorylases and nucleosideases
NO20054969D0 (no)	2005-10-26	2-cyanopropansyreamid- og esterderivater og deres anvendelse
IS8597A (is)	2007-01-24	Samsetningar rísedrónats og aðferðir við notkun þess
DK1603573T3 (da)	2008-09-15	Anvendelse af dipyridamol i kombination med acetylsalicylsyre og en angiotensin II-antagonist til forebyggelse af slagtilfælde
DK1626736T3 (da)	2020-09-28	C1-inhibitor med kort halveringstid til midlertidig behandling
DK1829874T3 (da)	2014-05-12	Tricyklisk forbindelse og anvendelse deraf
EP1688126A4 (en)	2009-11-04	PARAKERATOSIS HEMMER AND TOPICAL COMPOSITION FOR THE SKIN
ITRM20040058A1 (it)	2004-05-03	Inibitori ed antagonisti di hmgb1 in grado di regolare la proliferazione delle cellule muscolari lisce ed endoteliali.
DK1882054T3 (da)	2019-06-11	Korrosionsbeskyttelsesanordning og fremgangsmåde
DK1840121T3 (da)	2012-11-26	Glycinderivat og anvendelse heraf
IL178970A0 (en)	2007-03-08	Haplotype markers and methods of using the same to determine response to treatment